期刊
HUMAN GENETICS
卷 141, 期 5, 页码 1085-1091出版社
SPRINGER
DOI: 10.1007/s00439-021-02399-5
关键词
-
资金
- Wellcome Centre Grant [091580/Z/10/Z]
- Wellcome Investigator Award [107930/Z/15/Z]
- European Research Council [EC 694295]
- Wellcome [109090]
- Wellcome Trust [107930/Z/15/Z, 091580/Z/10/Z] Funding Source: Wellcome Trust
The review highlights the genetic basis of many neurological disorders and the efforts being made to develop genetic strategies for treating monogenic neurological disorders. It also addresses the challenges and ethical difficulties that may arise in the process.
In recent years, it has become increasingly apparent that many neurological disorders are underpinned by a genetic aetiology. This has resulted in considerable efforts to develop therapeutic strategies which can treat the disease-causing mutation, either by supplying a functional copy of the mutated gene or editing the genomic sequence. In this review, we will discuss the main genetic strategies which are currently being explored for the treatment of monogenic neurological disorders, as well as some of the challenges they face. In addition, we will address some of the ethical difficulties which may arise.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据